Cardiovascular & Blood Care Rx

Adilip 135mg Delayed-Release Tablets (Choline Fenofibrate)

Abbott’s advanced fibrate lipid-lowering tablet specifically formulated to sharply reduce triglycerides and elevate protective HDL cholesterol.

PHARMACEUTICAL SPECIFICATIONS

MANUFACTURER	Abbott Healthcare Pvt Ltd.
DOSAGE FORM	Delayed-Release Tablet
STRENGTH / SALT	Choline Fenofibrate (135 mg Delayed Release)
PACKAGING	Strip of 10 Tablets
STORAGE	Store at room temperature (15°C–30°C) in a dry place.
REGULATORY	Schedule H Prescription Drug
ITEM CODE	7384 · HSN: 30049099

Key Clinical Highlights

Choline Fenofibrate Active Metabolite
Reduces High Triglycerides by up to 50%
Can Be Prescribed with Statins under Medical Direction

Send an enquiry or call us for current stock and price confirmation.

ENQUIRE NOW WHATSAPP US

CLINICAL OVERVIEW & CARE

The details that matter.

Adilip 135 activates peroxisome proliferator-activated receptor alpha (PPARα) to accelerate the lipolysis and clearance of triglyceride-rich atherogenic particles from plasma. It is a cornerstone therapy for patients with mixed dyslipidemia or high cardiovascular risk.

METRICS & REASSURANCE

Confirm your item with the pharmacy.

Browse this range for information, then share the product name, strength and quantity. Our pharmacy team confirms availability, batch details, and medication guidance directly with you.

10,000+

MEDICINES

In-stock pharmaceutical catalog

5,000+

SURGICAL PRODUCTS

Hospital & clinic essentials

99%

AVAILABILITY*

Core essentials availability rate

LOCAL BRANCHES

Across our network

Up to 20%